Graham Capital Management, L.P. Castle Biosciences Inc Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 14,852 shares of CSTL stock, worth $501,700. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,852
Previous 12,190
21.84%
Holding current value
$501,700
Previous $270,000
19.63%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CSTL
# of Institutions
177Shares Held
25.8MCall Options Held
511KPut Options Held
100-
Black Rock Inc. New York, NY3.04MShares$103 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$78.6 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$53.3 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$52 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$41.1 Million0.44% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $888M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...